|
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
|
Mifepristone/Misoprostol
|
Methotrexate/Misoprostol
|
Misoprostol Only
|
|
Day 2-4 (Home): Misoprostol is self-administered vaginally at home. Nearly 2/3 of women will have a complete abortion within four hours of the misoprostol administration; 90% of women will have a complete abortion within 24 hours of misoprostol administration. Day 7-14 (Clinic): Patient returns to the clinic for follow-up and a clinician assesses for the completion of the abortion. If the abortion is incomplete (2%-5% of cases), the clinician will discuss treatment options with the patients. These options include waiting and re-evaluating, administering additional misoprostol, or performing an aspiration abortion. |
Day 3-7 (Home): Misoprostol is self-administered vaginally at home. Day 8 (Clinic): A clinician performs
a vaginal ultrasound to determine if the abortion is complete.
Day 15 (Clinic, if necessary): The patient is assessed for continued pregnancy. If cardiac activity is detected, a surgical termination is performed. If no cardiac activity is detected, the woman is asked to return in three weeks. Day 28-45 (Clinic, if necessary): The patient is assessed for continued pregnancy. If the abortion is incomplete (5% of cases), an aspiration termination is performed. |
Review of recent studies on the misoprostol-only regimen. |
Read our privacy statement.